Regulatory hurdles to delay vaccination in Brazil even further
This newsletter is for PREMIUM and STANDARD subscribers only. Become one now!
This week, we talk about the continuing hurdles preventing a vaccine from reaching Brazilians. And the question marks around the upcoming election in Congress.
Brazil’s vaccines hit regulatory hurdles
On Friday, federal health regulatory agency Anvisa received requests for the emergency approval of two coronavirus vaccines: one developed by AstraZeneca (the federal government’s main bet) and the Chinese-made CoronaVac.